Trametinib Dimethyl Sulfoxide
Overview
Trametinib Dimethyl Sulfoxide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2105741).
API suppliers (4)
Suppliers of Trametinib Dimethyl Sulfoxide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 4 suppliers.
2 of 4 hold a GMP certificate on record in the EU or UK registers
- ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
- VALARY LAB PRIVATE LIMITEDIndia1 active DMF GMP on record
- Biocon LimitedIndia1 active DMF
- Zhejiang Ausun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Trametinib Dimethyl Sulfoxide expires 28 Feb 2034 and exclusivity 16 Sept 2030. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide;methylsulfinylmethane
- Canonical SMILES
- CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5.CS(=O)C
- InChIKey
- OQUFJVRYDFIQBW-UHFFFAOYSA-N
Do you supply Trametinib Dimethyl Sulfoxide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.